EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Using machine learning for detection of Parkinson’s disease and mild cognitive impairment

Anthaea-Grace Patricia Dennis iD, Sarah L Martin, Robert Chen, Philip Gerretsen, Antonio P Strafella

PLOS One · 19.11.2025 · 20 (11) · e0335541

DOI: 10.1371/journal.pone.0335541 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 19.11.2025. Verfasst von Anthaea-Grace Patricia Dennis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Krembil Brain Institute, University Health Network, University of Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Parkinson Disease, Machine Learning. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institute of Health Research, Krembil-Rossy Chair Program, Queen Elizabeth II Graduate Scholarship in Science & Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson’s disease is a movement disorder featuring motor symptoms and cognitive decline, which can manifest as mild cognitive impairment. The incidence of mild cognitive impairment increases with disease progression, and Parkinson’s disease can cause significant disability, therefore, identification of Parkinson’s disease and mild cognitive impairment in Parkinson’s disease is imperative. Neuroimaging and biofluid biomarkers have been studied separately, however, research suggests that combining biomarkers may improve detection.

Objectives

We aimed to investigate using machine learning whether a combination of neuroimaging and biofluid biomarkers would result in more effective identification of Parkinson’s disease and mild cognitive impairment.

Methods

Utilizing the Parkinson’s Progression Markers Initiative dataset, we applied two different machine learning approaches, support vector machine and random forest, to explore combinations of neuroimaging and cerebrospinal fluid biomarkers for detection.

Results

Overall, both machine learning techniques had an equivalent performance. In general, in those models for detecting Parkinson’s disease, DaT-SPECT performed better than biofluid biomarkers. In models for detecting Parkinson’s disease patients with mild cognitive impairment, combining DaT-SPECT with phosphorylated-tau-181 resulted in higher accuracy, outperforming DaT-SPECT alone.

Conclusions

Classification for Parkinson’s disease and mild cognitive impairment may be improved by combining neuroimaging with biofluid biomarkers through machine learning models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionParkinson DiseaseMachine LearningHumansBiomarkersMaleFemaleAgedNeuroimagingMiddle AgedTomography, Emission-Computed, Single-PhotonSupport Vector Machine

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Krembil Brain Institute, University Health Network, University of Toronto, Ontario, Canada.
  • Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Ontario, Canada.
  • Brain Health Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, University of Toronto, Ontario, Canada.
  • Translational and Computational Neuroscience Unit, Faculty of Health and Education, Manchester Metropolitan University, Manchester, United Kingdom.
  • Edmond J. Safra Parkinson Disease Program & Morton and Gloria Shulman Movement Disorder Unit, Neurology Division, Dept. of Medicine, Toronto Western Hospital, University Health Network, University of Toronto, Ontario, C…
  • Department of Psychiatry, University of Toronto, Ontario, Canada.

ORCID-Profile: Anthaea-Grace Patricia Dennis

Förderung

  • Canadian Institute of Health Research
  • Krembil-Rossy Chair Program
  • Queen Elizabeth II Graduate Scholarship in Science & Technology
  • Krembil Brain Institute
  • University of Toronto School of Graduate Studies

Zitieren

APA

Dennis, A. P., Martin, S. L., Chen, R., Gerretsen, P., & Strafella, A. P. (2025). Using machine learning for detection of Parkinson’s disease and mild cognitive impairment. PLOS One, 20(11), e0335541. https://doi.org/10.1371/journal.pone.0335541

Vancouver

Dennis AP, Martin SL, Chen R, Gerretsen P, Strafella AP. Using machine learning for detection of Parkinson’s disease and mild cognitive impairment. PLOS One. 2025;20(11):e0335541. doi:10.1371/journal.pone.0335541

BibTeX
@article{Dennis2025,
  author = {Dennis, Anthaea-Grace Patricia and Martin, Sarah L and Chen, Robert and Gerretsen, Philip and Strafella, Antonio P},
  title = {Using machine learning for detection of Parkinson’s disease and mild cognitive impairment},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {11},
  pages = {e0335541},
  doi = {10.1371/journal.pone.0335541}
}
Kostenlos starten →